Company news
Impedimed Limited news in 2022
Impedimed Limited's news releases, calls and decks from 2022, newest first.
ImpediMed Announces Appointment of Managing Director and CEO
November 28, 2022
ImpediMed Announces Management Reorganisation
November 21, 2022
AstraZeneca Further Extends Clinical Trial Contract
November 9, 2022
Appendix 4C & Quarterly Activities Report - Sep-22 Qtr
October 19, 2022
New Corporate Oncology Account with GenesisCare
October 3, 2022
2022 Annual Report & Annual General Meeting Date
August 28, 2022
Appendix 4C & Quarterly Activities Report - Jun-2022 Qtr
July 27, 2022
ImpediMed CEO Announces Departure
July 25, 2022
Lymphoedema Risk Factors Paper Published
July 10, 2022
Appendix 4C & Quarterly Activities Report
April 27, 2022
AstraZeneca extends and increases Renal Contract
March 17, 2022
S&P DJI Announces March 2022 Quarterly Rebalance
March 4, 2022
ImpediMed Announces End Stage Renal Disease Trial Agreement
February 10, 2022
PREVENT Trial Peer-Reviewed and Published
January 31, 2022
Decks in 2022
- Bell Potter Healthcare Conference 2022
Conference · 17 slides · Nov 10, 2022
- Shareholder Meeting (October 2022)
Shareholder meeting · 10 slides · Oct 26, 2022